Spravato Treatment in Kansas
Esketamine therapy for adults with treatment-resistant depression.
At Interpersonal Psychiatry, we provide Spravato treatment in Kansas for patients who have not found relief with traditional antidepressant medications.
Treatment is available in Overland Park, Lawrence, and Topeka in a safe, supervised clinical setting with experienced psychiatric providers.
What Is Spravato?
Spravato is a prescription medication containing esketamine, a derivative of ketamine that targets brain pathways associated with mood regulation.
Unlike traditional antidepressants that primarily affect serotonin, Spravato works on the brain’s glutamate system and is administered as a nasal spray under medical supervision in certified treatment centers.
It is FDA-approved for adults with treatment-resistant depression and for depressive symptoms associated with major depressive disorder in certain clinical settings.
Spravato at a Glance
- FDA-approved esketamine treatment
- Administered as a nasal spray
- Given in a certified treatment center
- Monitored by medical professionals
- Often covered by insurance
Spravato vs. Ketamine Therapy
Both treatments affect the brain’s glutamate system, but there are important differences in how they are administered and used.
Spravato
- FDA-approved medication
- Administered as a nasal spray
- Must be given in certified treatment centers
- Often covered by insurance
Ketamine Infusion Therapy
- Typically administered intravenously
- May provide faster symptom relief for some patients
- Often used when other treatments have failed
- May differ in insurance coverage and treatment approach
How Spravato Treatment Works
Spravato works by targeting NMDA receptors that help regulate glutamate activity, one of the brain’s most important neurotransmitters involved in learning, memory, and mood regulation.
By affecting glutamate signaling, Spravato may help stimulate new neural connections and improve communication between brain cells.
- May help reduce depressive symptoms
- May improve emotional resilience
- May support neural pathways involved in mood regulation
- May improve overall mental functioning
What to Expect During Spravato Treatment
Before Treatment
Your first visit is typically a consultation with a provider. Patients must be registered with the SPRAVATO REMS program and may require insurance prior authorization before starting treatment.
During Treatment
Patients self-administer the nasal spray under medical supervision and remain in the clinic for observation while providers monitor response and vital signs.
Session Length
Each treatment session lasts about two hours, including observation time after administration.
Transportation
Patients should not drive after treatment and need transportation home from a friend, family member, or rideshare service.
Typical Schedule
Spravato treatment often begins with two sessions per week for four weeks, followed by weekly treatments, then maintenance sessions as recommended.
Individualized Care
Treatment schedules can vary depending on your symptoms, response, and provider recommendations.
Who May Be a Candidate for Spravato?
Spravato is typically recommended for adults with treatment-resistant depression who continue to experience significant symptoms despite trying traditional antidepressant medications.
- Adults with major depressive disorder
- Individuals who have tried multiple antidepressants without success
- Patients with ongoing significant depressive symptoms
- People who may need treatment beyond traditional medications
Is Spravato Safe?
Spravato is FDA-approved and administered under strict medical supervision in certified treatment centers.
Possible Side Effects
- Dizziness
- Nausea
- Dissociation
- Increased blood pressure
- Temporary sedation
Why Monitoring Matters
Because treatment occurs in a medical setting with observation, providers can monitor patient safety and respond to concerns during treatment.
Clinical Oversight
Many patients tolerate Spravato therapy well and experience symptom improvements while receiving supervised care.
Benefits of Spravato Treatment
Spravato Treatment Locations in Kansas
Interpersonal Psychiatry offers Spravato treatment through clinics in Overland Park, Lawrence, and Topeka.
Overland Park
Serving Johnson County and the Kansas City metro area.
Lawrence
Serving Douglas County and surrounding communities.
Topeka
Serving Shawnee County and northeastern Kansas.
Schedule a Spravato Consultation in Kansas
If you are struggling with treatment-resistant depression, Spravato therapy may provide a new opportunity for relief. Our team can help you determine whether it may be right for you.
Schedule Appointment